Cole William C, Chen Tim T, Clément-Chomienne Odile
The Smooth Muscle Research Group, Department of Pharmacology & Therapeutics, Universityk of Calgary, Calgary, Canada.
Can J Physiol Pharmacol. 2005 Aug-Sep;83(8-9):755-65. doi: 10.1139/y05-082.
The phenomenon of myogenic constriction of arterial resistance vessels in response to increased intraluminal pressure has been known for over 100 years, yet our understanding of the molecular mechanisms involved remains incomplete. The focus of this paper concerns the potassium (K+) channels that provide a negative feedback control of the myogenic depolarization of vascular smooth muscle cells that is provoked by elevations in intraluminal pressure, and specifically, the contribution of delayed rectifier (KDR) channels. Our knowledge of the important role played by KDR channels, as well as their molecular identity and acute modulation via changes in gating, has increased dramatically in recent years. Several lines of evidence point to a crucial contribution by heteromultimeric KV1 subunit-containing KDR channels in the control of arterial diameter and myogenic reactivity, but other members of the KV superfamily are also expressed by vascular myocytes, and less is known concerning their specific functions. The effect of pharmacological modulation of KDR channels is discussed, with particular reference to the actions of anorexinogens on KV1- and KV2-containing KDR channels. Finally, the need for a greater understanding of the mechanisms that control KDR channel gene expression is stressed in light of evidence indicating that there is a reduced expression of KDR channels in diseases associated with abnormal myogenic reactivity and vascular remodelling.
动脉阻力血管对管腔内压力升高产生肌源性收缩的现象已为人所知达100多年,但我们对其中涉及的分子机制的理解仍不完整。本文重点关注钾(K+)通道,这些通道对管腔内压力升高引发的血管平滑肌细胞肌源性去极化提供负反馈控制,特别是延迟整流器(KDR)通道的作用。近年来,我们对KDR通道所起的重要作用及其分子特性以及通过门控变化进行的急性调节的了解有了显著增加。几条证据表明,含有异源多聚体KV1亚基的KDR通道在控制动脉直径和肌源性反应性方面起关键作用,但KV超家族的其他成员也由血管肌细胞表达,而关于它们的具体功能了解较少。本文讨论了KDR通道药理学调节的作用,特别提及了食欲素原对含KV1和KV2的KDR通道的作用。最后,鉴于有证据表明在与异常肌源性反应性和血管重塑相关的疾病中KDR通道表达降低,强调了更深入了解控制KDR通道基因表达机制的必要性。